Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Dr. Fisher is a clinical ophthalmologist specializing in vitreoretinal diseases. Dr. Fisher’s career is noteworthy in the areas of patient care, teaching, and research. He is the author of several textbooks in the field of vitreoretinal diseases and ultrasonography.AuthorDr. Fisher has published more than 50 scientific articles and numerous scientific exhibits and posters. He was a course director for the American Academy of Ophthalmology for over 22 years and a review editor for many prestigious ophthalmic journals. He has received numerous awards for national and international professorships and lectureships. He has also been awarded the coveted Senior Award from the American Academy of Ophthalmology.LecturesDr. Fisher has lectured throughout the United States and abroad in the areas of ultrasonography and vitreoretinal surgery, developing new techniques and instruments in his field as well as pioneering developments in ocular endoscopy. He was selected by departmental chairmen and section chiefs at major ophthalmology centers nationwide as one of the 400 best retina doctors in America.Developed InstrumentsDr. Fisher has developed numerous intraocular surgical instruments which have advanced the field of vitreoretinal surgery. These instruments include electromagnets as well as endoscopic techniques for situations where microscopic visualization is limited or impossible. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), Retinal Detachment, and Vitrectomy.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Stargardt Macular Degeneration, and Cone Rod Dystrophy Amelogenesis Imperfecta.

Kenneth Wald is an Ophthalmologist in Rego Park, New York. Dr. Wald is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Detachment, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Vitrectomy.

Sangwoo Lee is an Ophthalmologist in New York, New York. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Geographic Atrophy.

Philip Ferrone is an Ophthalmologist in Elmhurst, New York. Dr. Ferrone is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy.

Dr. Albert Li is a board-certified, fellowship-trained vitreoretinal surgeon at Vitreoretinal Consultants of New York, a member of the Northwell Health Eye Institute. He speaks English, Mandarin Chinese and Spanish.Dr. Li specializes in diseases and surgery of the vitreous and retina, including diabetic retinopathy, age-related macular degeneration, retinal vascular occlusions, retinal detachments, macular puckers, macular holes, and cataract complications. Dr. Li is dedicated to providing compassionate care to all of his patients, employing the latest technology and applying the most up-to-date medical research in order to meet the specific needs of each patient he sees.Dr. Li graduated magna cum laude with highest honors in Chemical and Physical Biology from Harvard College. He was awarded the Thomas Temple Hoopes Prize for his undergraduate research thesis at Harvard College and inducted into The Phi Beta Kappa Society. He earned his medical degree from New York University School of Medicine and obtained his ophthalmology residency training at Hofstra Northwell School of Medicine at North Shore University Hospital and Long Island Jewish Medical Center, serving as chief resident in his final year. He then completed his vitreoretinal fellowship at Barnes-Jewish Hospital/Washington University School of Medicine in St. Louis, where he also held an academic appointment as an Instructor in Ophthalmology.Dr. Li is board certified by the American Board of Ophthalmology and a member of the American Society of Retina Specialists and the American Academy of Ophthalmology. He is currently a Clinical Assistant Professor of Ophthalmology at Zucker School of Medicine at Hofstra/Northwell, and previously served as Assistant Professor of Ophthalmology at University of Maryland School of Medicine, where he was honored as Faculty of the Year for excellence in resident teaching. Dr. Li has authored many peer-reviewed articles in the medical literature and regularly presents his clinical research at national and international ophthalmology meetings. He continues to be engaged in clinical research in retinal diseases as well as the education and training of medical students and residents in ophthalmology. Dr. Li is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Artery Occlusion, Diabetic Retinopathy, Late-Onset Retinal Degeneration, Retinal Vein Occlusion, and Vitrectomy.

Nicholas Nissirios is an Ophthalmologist in Astoria, New York. Dr. Nissirios is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Dry Eye Syndrome, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Eyelid Bump. Dr. Nissirios is currently accepting new patients.

"William M. Schiff, MD is a board certified Ophthalmologist, specializing in the medical and surgical management of vitreous and retinal diseases. He is the Director of Ophthalmic Surgery at Manhattan Eye Ear and Throat Hospital (MEETH) and serves an educational role as the Co-Director of the Vitreoretinal Fellowship Program. Dr. Schiff's practice encompasses the management of medical and surgical diseases of the vitreous, retina, and macula including macular degeneration, macular hole, epiretinal membrane, diabetic retinopathy and retinal detachment. Dr. Schiff was previously Professor of Clinical Ophthalmology at Columbia University, College of Physicians and Surgeons. He has lectured widely, has authored or coauthored more than 50 publications, and is an active member of numerous professional societies and organizations including The American Academy of Ophthalmology, The Retina Society, The American Society of Retinal Specialists and the New York Ophthalmologic Society. Dr. Schiff has earned the Achievement Award from the American Academy of Ophthalmology and the Honor's Award from the American Society of Retina Specialists. He has been named in ""New York Magazine's Best Doctors. Dr. Schiff is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Vitrectomy, and Cataract Removal.

Dr. Barile is Professor of Ophthalmology, Zucker School of Medicine at Hofstra /Northwell, and Director of Ophthalmology Research, Manhattan Eye, Ear and Throat Hospital. He previously served as the John Wilson Espy MD Professor of Clinical Ophthalmology and Glaubinger Scholar in Retina Research at Columbia University. Dr. Barile has lectured widely, has authored or coauthored more than eighty publications, and is a member of numerous professional societies and organizations including the Macula and Retina Societies. Among several honors, Dr. Barile received an Achievement Award from the American Academy of Ophthalmology and a Senior Honor Award from the American Society of Retina Specialists. Dr. Barile is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Retinal Detachment, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Vitrectomy.

Naomi Goldberg is an Ophthalmologist in New York, New York. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, and Neuroretinitis.

Michael Engelbert, MD, PhD, a vitreoretinal surgeon and macular disease specialist, provides both medical care for age-related macular degeneration and diabetic eye disease as well as surgical management of macular disease and retinal detachment repair, including complex detachments from diabetes and after trauma or failed primary repair. He also specializes in secondary intraocular lens implantation after complicated cataract surgery. He is an internationally renowned expert on vitreous anatomy and vitreoretinal interface disorders, topics on which he lectures at home and abroad.Dr. Engelbert received his medical degree Magna Cum Laude from Ludwig-Maximilians-University in Munich, Germany, after which he dedicated himself several years to basic research in the study of endophthalmitis, a vision-threatening infection, that can occur after eye surgery. He earned a Ph.D. for this work and is considered a leader in this field.Before joining the residency program at Columbia University, Dr. Engelbert served his internship at Griffin Hospital, a Yale-affiliated center in Connecticut, where he was granted the Vincent D. DeLuca award for the best medical intern.Afterward, he was resident and chief resident in the Department of Ophthalmology of Columbia University’s College of Physicians and Surgeons at the Edward S. Harkness Eye Institute on the Columbia Presbyterian Medical Center Campus. Following his residency training, Dr. Engelbert was awarded a medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University.Dr. Engelbert is a member of The American Society of Retina Specialists (ASRS), The European Society of Vitreoretinal Specialists (EVRS), the Association for Research in Vision and Ophthalmology (ARVO), and The American Academy of Ophthalmology (AAO) and the prestigious Club Jules Gonin. He has published numerous papers on retinal disease, received several awards and has been granted permanent resident status in the United States in the category “outstanding scientist”. He serves as a reviewer for the premier journals in the field, including the Archives of Ophthalmology, Ophthalmology, Investigative Ophthalmology and Visual Sciences, Retina, Eye, and Graefe’s Archives of Clinical and Experimental Ophthalmology.He is a Research Assistant Professor at New York University and Clinical Instructor at NYU , where he is actively involved in instructing residents and fellows in the art of medical retina and retinal surgery, and provides care for an underserved population with often advanced disease requiring complex surgical intervention. Dr. Engelbert is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

Dr. Klancnik utilizes all forms of ophthalmic imaging including fluorescein angiography, indocyanine green angiography, as well as noninvasive forms of imaging such as spectral domain optical coherence tomography, autofluorescence photography, and ultrasonography.Dr. Klancnik is a magna cum laude graduate of Yale University. He earned his medical degree from Jefferson Medical College of Thomas Jefferson University and was elected to the Alpha Omega Alpha and Hobart Amory Hare honor medical societies. He completed his internship at the Lankenau Hospital and his ophthalmology residency at Wills Eye Hospital. He completed his medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University. He is an Assistant Professor of Clinical Ophthalmology at New York University School of Medicine.Dr. Klancnik is a member of numerous medical organizations including the American Academy of Ophthalmology, American Society of Retinal Specialists, and Association for Research in Vision and Ophthalmology. He is an author of numerous peer-reviewed journal articles and book chapters and has presented at scientific meetings nationally and internationally. He is active in numerous clinical trials as principle or sub-investigator and serves as a reviewer for several ophthalmology journals. Dr. Klancnik is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.

Irene A. Barbazetto, M.D. is a vitreoretinal surgeon and macular disease specialist board certified in the United States and Europe. She is an internationally recognized expert in the treatment of macular degeneration, retinal vascular disease, retinal vein occlusion, hereditary retinal disease, and diabetes.The author of more than 40 peer-reviewed articles and book chapters, she serves on the Editorial Board of the prestigious journal Graefe’s Archive of Clinical and Experimental Ophthalmology. Dr. Barbazetto is the recipient of the 2009 Achievement Award from the American Academy of Ophthalmology. Her patients voted her as one of the best retina doctors, America’s “Most Compassionate Physicians,” and she received the “Patient’s Choice Award” in 2010. A graduate of Hamburg University, Germany, Dr. Barbazetto’s doctoral thesis investigated a newly developed vision-screening test (H-Test) for pre-school children and was awarded cum laude. She completed her ophthalmology residency in Lübeck, Germany, where she participated in the development of photodynamic therapy for the treatment of macular degeneration.In 2000, she came to New York for a research fellowship with Dr. Stanley Chang at Columbia University, focusing on the role of oxygen in the development of cataract after vitreoretinal surgery. She completed an internship in general surgery at the Lenox Hill Hospital in Manhattan and an ophthalmology residency at Columbia University. Dr. Barbazetto is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Adult-Onset Vitelliform Macular Dystrophy (AVMD).

Joseph Panarelli is an Ophthalmologist in New York, New York. Dr. Panarelli is rated as an Experienced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Vitrectomy. Dr. Panarelli is currently accepting new patients.

Ronni Lieberman is an Ophthalmologist in Elmhurst, New York. Dr. Lieberman is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Artery Occlusion, Diabetic Retinopathy, Retinal Vein Occlusion, Glaucoma, and Vitrectomy.

Julia Shulman is an Ophthalmologist in Forest Hills, New York. Dr. Shulman is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Detachment. Dr. Shulman is currently accepting new patients.

Zimei Zhou is an Ophthalmologist in Flushing, New York. Dr. Zhou is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Retinal Artery Occlusion, and Vitrectomy. Dr. Zhou is currently accepting new patients in some locations.

James Lin is an Ophthalmologist in Flushing, New York. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Diabetic Retinopathy, X-Linked Retinal Dysplasia, X-Linked Juvenile Retinoschisis, and Late-Onset Retinal Degeneration.

Jessica Lee is an Ophthalmologist in Flushing, New York. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).